Company intelligence / Profile preview

RxLogix

Aventura, Florida, United States of Americarxlogix.com ↗

Ownership: Private
Employees: ~500
Development stage: Commercial

Overview

RxLogix provides industry-leading pharmacovigilance and drug safety software platforms used by major regulatory agencies such as the FDA and top global biotech companies. Their solutions leverage AI and machine learning to improve adverse event detection, signal management, compliance reporting, and benefit-risk assessment. The company’s platforms are recognized for innovation and user-friendliness.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

U.S. Food & Drug Administration (FDA) – selected as vendor to replace legacy FAERS signaling system with RxLogix’s platform.

Beyond the preview

Go deeper on RxLogix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RxLogix.

Explore the full profile